Large-caps gain on CPI data 📈

Good Afternoon! 

Hey, everyone. It's Adam from Elite Trade Club. 

I hope you had a great trading session. Here’s what moved the market today.

Markets 📈

America’s large-cap indexes gained again on Tuesday, after November’s CPI report showed the country’s fight against inflation continues to make progress, but the small-cap Russell 2K posted a small loss on the session..

Sponsored

These AI Stocks Could Skyrocket in Value!

AI stocks could surge to $2 trillion valuation in just 7 years, so, even after 2023’s big gains, there’s still plenty of upside potential in the AI trade.

In fact, billionaire tech mogul Mark Cuban believes early AI investors could become the first class of stock market TRILLIONAIRES!

This list features the Top-5 AI Stocks for monumental growth, and their next big breakout could be right around corner.

Get the Top-5 AI Stocks on the Next Page »

Market-Moving News 🔎 

🏛 The Fed's Take on November’s CPI Report

As the Federal Reserve heads into its December meeting, today's CPI report suggests that inflation is slowing, but uncertainties remain.

The economy's cooling trend and a consistent downtrend in inflation have bolstered confidence among Fed officials that further rate hikes might not be necessary.

🔍 Core CPI in Focus: 
While the overall CPI offers some reassurance, the core CPI – which excludes the more volatile food and energy sectors – indicates that the journey to stable inflation isn't straightforward.

November's core CPI mirrored October's 4% year-over-year increase, with a six-month annualized trend showing a slight improvement from 3.2% in October to 2.9% in November.

📉 Potential Upward Trend Ahead: 
Analyst Omair Sharif from Inflation Insights warns that this trend could reverse, with the six-month annualized rate potentially rising to an average of 3.5% in early 2024.

💡 Long Road to Inflation Target: 
This CPI report paints a picture of an extended journey towards the Fed's 2% inflation goal, potentially challenging the market's more optimistic expectations.

In summary, while today's CPI report provides some positive signals, it also highlights the complexities and unpredictability of inflation trends, suggesting a cautious approach from the Fed as it navigates the path back to its inflation target.

C4 Therapeutics [CCCC] $2.34 (+98.3%)
announced a new licensing & research deal with Pharma Giant Merck [MRK 0.0%] for $10 million upfront and $600 million in potential milestones.

Aditx [ADTX] $6.09 (+60.2%)
made a deal to acquire Evofem Biosciences for about $100 million worth of common stock, preferred stock, and debt considerations.

Icosavax [ICVX] $15.68 (+49.4%)
agreed to be acquired by AstraZeneca [AZN +0.0%] for $15 per share, plus a contingent value right for another $5 in cash.

EF Hutton SPAC [EFHT] $2.93 (+59.9%)
successfully closed its merger with ECD Auto Design. Tomorrow, it will make its Nasdaq Global Market debut under the ticker symbol ECDA.

Achieve Life Sciences [ACHV] $3.15 (42.2%) 
fell after it revealed details of a meeting with FDA regulators regarding a new drug application for its drug candidate, cytisinicline.

Kaixin Auto [KXIN] $1.28 (20.9%) 
pulled back after announcing the establishment of a new AI automotive research group a day earlier.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback from our members!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Text ELITESTOCKS to 47121 or click here to get our alerts on your mobile device, and never miss another fast-moving stock!

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.